Targeting folate receptor alpha for cancer treatmentAnthony Cheung, Sophia N. Karagiannis|Oncotarget|2016Cited by 447
A Novel Antibody-Drug Conjugate (ADC) Delivering a DNA Mono-Alkylating Payload to Chondroitin Sulfate Proteoglycan (CSPG4)-Expressing MelanomaRicarda M. Hoffmann, Sophia N. Karagiannis|Cancers|2020Cited by 38
Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trialJames Spicer, Sophia N. Karagiannis, Ana Montes et al.|Nature Communications|2023Cited by 35
Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer GrowthAnthony Cheung, Sophia N. Karagiannis|Clinical Cancer Research|2024Cited by 27
Functionally Active Fc Mutant Antibodies Recognizing Cancer Antigens Generated Rapidly at High YieldsKristina M. Ilieva, Sophia N. Karagiannis|Frontiers in Immunology|2017Cited by 15